Peripartum cardiomyopathy (PPCM) is a deterioration in cardiac function that occurs in pregnant women during the last month or in the months following their pregnancy. This disorder can occur in women with no prior history of heart disease and the causes are not well understood.
In this issue of the Journal of Clinical Investigation, Ingrid Struman and colleagues at the University of Liege in Liege, Belgium, identified a molecule, miR-146a, that can serve as a biomarker for peripartum cardiomyopathy. Struman and colleagues found that expression of miR-146a was induced by the nursing hormone prolactin. MiR-146a expression promoted vascular damage and was increased in a mouse model of PPCM. Conversely, loss of miR-146a in mice prevented PPCM. Importantly, miR-146a expression was elevated in the serum of pregnant women who developed PPCM, suggesting that serum miR-146a levels could predict which patients are at risk for the disease.
In a companion commentary, Richard Kitsis of Albert Einstein College of Medicine in New York, discusses the potential implications of this work for the identification and treatment of PPCM.
TITLE: MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
View this article at: http://www.jci.org/articles/view/64365?key=54a58644d5c203c3b462
ACCOMPANYING COMMENTARY TITLE: A microRNA links prolactin to peripartum cardiomyopathy
View this article at: http://www.jci.org/articles/view/69286?key=ea00e37108ce3ec09bd1
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.Visit our heart disease section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:
MLA
8 May. 2013.
Please note: If no author information is provided, the source is cited instead.
'Discovery Of A Potential Biomarker For Pregnancy-Related Heart Disease'
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


22:27
abgajoy
Posted in: 
0 comments:
Post a Comment